CAM
CRVO icon

Crown Advisors Management’s CervoMed CRVO Stock Holding History

Crown Advisors Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,000
Closed -$1.46M – 38
2024
Q3 		$1.46M Hold
100,000
– – 0.94% 35
2024
Q2 		$1.71M Hold
100,000
– – 1.1% 31
2024
Q1 		$2.33M Buy
+100,000
New +$1.33M 1.41% 24

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Crown Advisors Management's CRVO Position: Q4 2024 in Review

Crown Advisors Management sold out of CervoMed (CRVO) in Q4 2024, closing a stake of 100,000 shares — an estimated $1.46M sold.

Crown Advisors Management first reported a position in CRVO in Q1 2024 and held it in 3 quarters. The position peaked at $2.33M in Q1 2024. 49 funds tracked by Wall St. Rank hold CRVO as of Q4 2024.

  • Crown Advisors Management reported no remaining CervoMed position as of Q4 2024 after selling out during the quarter.
  • Crown Advisors Management sold 100,000 CervoMed shares in Q4 2024, an estimated $1.46M.
  • Crown Advisors Management first reported a position in CervoMed in Q1 2024 and held it in 3 quarters.
  • Crown Advisors Management's CervoMed position peaked at $2.33M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held CervoMed as of Q4 2024.

Based on Crown Advisors Management's 13F filing for Q4 2024, filed 11 Feb 2025.